Literature DB >> 29879430

MEF2 and the tumorigenic process, hic sunt leones.

Eros Di Giorgio1, Wayne W Hancock2, Claudio Brancolini3.   

Abstract

While MEF2 transcription factors are well known to cooperate in orchestrating cell fate and adaptive responses during development and adult life, additional studies over the last decade have identified a wide spectrum of genetic alterations of MEF2 in different cancers. The consequences of these alterations, including triggering and maintaining the tumorigenic process, are not entirely clear. A deeper knowledge of the molecular pathways that regulate MEF2 expression and function, as well as the nature and consequences of MEF2 mutations are necessary to fully understand the many roles of MEF2 in malignant cells. This review discusses the current knowledge of MEF2 transcription factors in cancer.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Class IIa HDAC; MEF2A; MEF2B; MEF2C; MEF2D; P300

Mesh:

Substances:

Year:  2018        PMID: 29879430     DOI: 10.1016/j.bbcan.2018.05.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  20 in total

1.  LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis.

Authors:  Tatsuya Morishima; Ann-Christin Krahl; Masoud Nasri; Yun Xu; Narges Aghaallaei; Betül Findik; Maksim Klimiankou; Malte Ritter; Marcus D Hartmann; Christian Johannes Gloeckner; Sylwia Stefanczyk; Christian Lindner; Benedikt Oswald; Regine Bernhard; Karin Hähnel; Ursula Hermanutz-Klein; Martin Ebinger; Rupert Handgretinger; Nicolas Casadei; Karl Welte; Maya Andre; Patrick Müller; Baubak Bajoghli; Julia Skokowa
Journal:  Blood       Date:  2019-07-31       Impact factor: 22.113

Review 2.  Emerging roles for MEF2 in brain development and mental disorders.

Authors:  Ahlem Assali; Adam J Harrington; Christopher W Cowan
Journal:  Curr Opin Neurobiol       Date:  2019-05-23       Impact factor: 6.627

3.  Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription.

Authors:  Martina Minisini; Eros Di Giorgio; Emanuela Kerschbamer; Emiliano Dalla; Massimo Faggiani; Elisa Franforte; Franz-Josef Meyer-Almes; Rino Ragno; Lorenzo Antonini; Antonello Mai; Francesco Fiorentino; Dante Rotili; Monica Chinellato; Stefano Perin; Laura Cendron; Christian X Weichenberger; Alessandro Angelini; Claudio Brancolini
Journal:  Nucleic Acids Res       Date:  2022-03-21       Impact factor: 16.971

4.  Myocyte enhancer factor 2D promotes hepatocellular carcinoma through AMOTL2/YAP signaling that inhibited by luteolin.

Authors:  Qianqian Xu; Bing Gao; Xinlin Liu; Xin Zhang; Lili Wu; Dongming Xing; Leina Ma; Jia Liu
Journal:  Int J Clin Exp Pathol       Date:  2022-05-15

5.  MEF2D sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity.

Authors:  Eros Di Giorgio; Liqing Wang; Yan Xiong; Tatiana Akimova; Lanette M Christensen; Rongxiang Han; Arabinda Samanta; Matteo Trevisanut; Tricia R Bhatti; Ulf H Beier; Wayne W Hancock
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

6.  MEF2A transcriptionally upregulates the expression of ZEB2 and CTNNB1 in colorectal cancer to promote tumor progression.

Authors:  Qing Xiao; Yaqi Gan; Yimin Li; Lili Fan; Jiaqi Liu; Pengyan Lu; Jiaxin Liu; Aoao Chen; Guang Shu; Gang Yin
Journal:  Oncogene       Date:  2021-04-16       Impact factor: 9.867

Review 7.  Role of Calcium Signaling in Prostate Cancer Progression: Effects on Cancer Hallmarks and Bone Metastatic Mechanisms.

Authors:  Juan A Ardura; Luis Álvarez-Carrión; Irene Gutiérrez-Rojas; Verónica Alonso
Journal:  Cancers (Basel)       Date:  2020-04-25       Impact factor: 6.639

8.  HDAC7-mediated control of tumour microenvironment maintains proliferative and stemness competence of human mammary epithelial cells.

Authors:  Valentina Cutano; Eros Di Giorgio; Martina Minisini; Raffaella Picco; Emiliano Dalla; Claudio Brancolini
Journal:  Mol Oncol       Date:  2019-06-27       Impact factor: 6.603

9.  A Biological Circuit Involving Mef2c, Mef2d, and Hdac9 Controls the Immunosuppressive Functions of CD4+Foxp3+ T-Regulatory Cells.

Authors:  Eros Di Giorgio; Liqing Wang; Yan Xiong; Lanette M Christensen; Tatiana Akimova; Rongxiang Han; Arabinda Samanta; Matteo Trevisanut; Claudio Brancolini; Ulf H Beier; Wayne W Hancock
Journal:  Front Immunol       Date:  2021-07-05       Impact factor: 7.561

10.  ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency.

Authors:  Zhendong Cao; Krista A Budinich; Hua Huang; Diqiu Ren; Bin Lu; Zhen Zhang; Qingzhou Chen; Yeqiao Zhou; Yu-Han Huang; Fatemeh Alikarami; Molly C Kingsley; Alexandra K Lenard; Aoi Wakabayashi; Eugene Khandros; Will Bailis; Jun Qi; Martin P Carroll; Gerd A Blobel; Robert B Faryabi; Kathrin M Bernt; Shelley L Berger; Junwei Shi
Journal:  Mol Cell       Date:  2021-08-05       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.